Quinolinones as Inhibitors of Translation Initiation Complex
申请人:Sanford-Burnham Medical Research Institute
公开号:US20180044324A1
公开(公告)日:2018-02-15
Provided herein are compounds and pharmaceutical compositions comprising quinolinones. The quinolinones and compositions thereof are useful as eukaryotic translation initiation factor 4F (eIF4F) complex modulators.
Green chemical approach: microwave assisted, titanium dioxide nanoparticles catalyzed, convenient and efficient C–C bond formation in the synthesis of highly functionalized quinolines and quinolinones
These approaches lead to the synthesis of hitherto unknown compounds with a varied substitution pattern by both conventional and microwave‐assisted method. A good number of analogues were evaluated for their in vitro cytotoxicity against human cervical and colon cancer cell lines by MTT protocol. Almost all the selected compounds showed remarkable cytotoxic activities. Among them, compound 4g and 4i
Quinolinones as inhibitors of translation initiation complex
申请人:Sanford Burnham Prebys Medical Discovery Institute
公开号:US10577349B2
公开(公告)日:2020-03-03
Provided herein are compounds and pharmaceutical compositions comprising quinolinones. The quinolinones and compositions thereof are useful as eukaryotic translation initiation factor 4F (eIF4F) complex modulators.
A method to derive functionalized biquinoline- and quinoline-bearing chromene bicyclic systems through aryl-aryl bond formation in a one-pot synthesis is described. The X-ray structure analysis provides insight into the mode of orientation of the molecules and opens the way to the synthesis of various hybrid molecules by making use of suitable substituents at R-1, R-2, and R-3.